Rebecca Chambers sold $622K of Veracyte (VCYT)

Executed Dec 4 2025, disclosed Dec 4 2025, the same day.

Value, as filed

$622K

13,278 sh across 2 lots

Executed

Dec 4 2025

the trade date, as filed

Disclosed

Dec 4 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Rebecca Chambers Chief Financial Officer profile →

Rebecca Chambers (Chief Financial Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $663K of VCYT (18,341 sh across 2 lots, as filed), executed Mar 4.

The name

VCYT

Veracyte, Inc. VCYT · Healthcare · 48 filings in 24 months ticker →

Healthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Rebecca Chambers in VCYT

VCYTSALE Veracyte, Inc. $106K
2,477 sh × $42.81
Exec Sep 4
Filed Sep 4 · 7:54 PM ET VCYTSALE Veracyte, Inc. $663K
18,341 sh across 2 lots
Exec Mar 4
Filed Mar 6 · 5:30 PM ET VCYTSALE Veracyte, Inc. $287K
7,000 sh × $41.00
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $303K
7,000 sh × $43.23
Exec Dec 3 2024
Filed Dec 4 2024 · 5:30 PM ET VCYTSALE Veracyte, Inc. $586K
15,275 sh × $38.34
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET